Cargando…
Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
Cholera is a severe diarrheal disease caused by the bacterium Vibrio cholerae (V. cholerae) that results in 3–4 million cases globally with 100,000–150,000 deaths reported annually. Mostly confined to developing nations, current strategies to control the spread of cholera include the provision of sa...
Autores principales: | Davitt, Christopher J. H., Longet, Stephanie, Albutti, Aqel, Aversa, Vincenzo, Nordqvist, Stefan, Hackett, Becky, McEntee, Craig P., Rosa, Monica, Coulter, Ivan S., Lebens, Michael, Tobias, Joshua, Holmgren, Jan, Lavelle, Ed C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746523/ https://www.ncbi.nlm.nih.gov/pubmed/30953000 http://dx.doi.org/10.1038/s41385-019-0159-z |
Ejemplares similares
-
An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses
por: Longet, Stephanie, et al.
Publicado: (2019) -
Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines
por: Albutti, Aqel, et al.
Publicado: (2021) -
A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae
por: Terrinoni, Manuela, et al.
Publicado: (2018) -
Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant
por: Singh, Shailbala, et al.
Publicado: (2014) -
Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation
por: McEntee, Craig P., et al.
Publicado: (2019)